Skip to main content

Table 2 Tumor response, failure Pattern and survival

From: Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

 

CRT-alone

CRT-AC

Total

p*

Tumor response, n (%)

   

0.91

 CR

26 (26.5)

24 (27.0)

50 (26.7)

 

 PR

37 (37.8)

30 (33.7)

67 (35.8)

 

 SD

31 (31.6)

32 (36.0)

63 (33.7)

 

 PD

4 (4.1)

3 (3.3)

7 (3.7)

 

Pattern of failure, n (%)

   

0.399

 Locoregional alone

30(16.1)

35(18.7)

65(34.8)

 

 Locoregional and distant

6 (3.2)

2 (1.1)

8(4.3)

 

 Distant alone

26 (13.9)

21 (11.2)

47(25.1)

 

1, 2,5 y survival rates (%)

 OS

66.7, 39.1, 27.6

75.3, 47.1, 26.9

67.5,41.4, 27.2

0.732

 LFFS

70.4, 57.2, 55.1

69.7, 58.6,49.8

68.7,57.9, 52.4

0.876

 DFFS

74.1, 65.3, 63

83.3, 73, 65.4

78.5, 68.9, 63.9

0.200

  1. *: p value between CRT-alone and CRT-AC